Exchange Traded Concepts’s Mesa Laboratories MLAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-2,981
Closed -$495K 1226
2022
Q4
$495K Buy
2,981
+80
+3% +$12.5K 0.01% 526
2022
Q3
$409K Sell
2,901
-2,173
-43% -$396K 0.01% 515
2022
Q2
$1.03M Buy
5,074
+146
+3% +$32K 0.03% 282
2022
Q1
$1.26M Buy
4,928
+482
+11% +$131K 0.03% 301
2021
Q4
$1.46M Buy
4,446
+75
+2% +$23.5K 0.03% 281
2021
Q3
$1.32M Buy
4,371
+611
+16% +$174K 0.03% 277
2021
Q2
$1.02M Buy
3,760
+348
+10% +$88.3K 0.03% 318
2021
Q1
$831K Buy
3,412
+422
+14% +$116K 0.03% 322
2020
Q4
$857K Buy
2,990
+288
+11% +$79.2K 0.04% 246
2020
Q3
$688K Buy
2,702
+707
+35% +$168K 0.04% 221
2020
Q2
$433K Buy
+1,995
New +$460K 0.07% 237

Other funds holding MLAB

Exchange Traded Concepts's MLAB Position: Q1 2023 in Review

Exchange Traded Concepts sold out of Mesa Laboratories (MLAB) in Q1 2023, closing a stake of 2,981 shares — an estimated $495K sold.

Exchange Traded Concepts first reported a position in MLAB in Q2 2020 and held it in 11 quarters. The position peaked at $1.46M in Q4 2021. 160 funds tracked by Wall St. Rank hold MLAB as of Q1 2023.

  • Exchange Traded Concepts reported no remaining Mesa Laboratories position as of Q1 2023 after selling out during the quarter.
  • Exchange Traded Concepts sold 2,981 Mesa Laboratories shares in Q1 2023, an estimated $495K.
  • Exchange Traded Concepts first reported a position in Mesa Laboratories in Q2 2020 and held it in 11 quarters.
  • Exchange Traded Concepts's Mesa Laboratories position peaked at $1.46M in Q4 2021.
  • 160 funds tracked by Wall St. Rank held Mesa Laboratories as of Q1 2023.

Based on Exchange Traded Concepts's 13F filing for Q1 2023, filed 12 Apr 2023.